Search Result "rapastinel"
The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 47-56
Author(s): Joseph R. Moskal, Jeffrey S. Burgdorf, Patric K. Stanton, Roger A. Kroes, John F. Disterhoft, Ronald M. Burch, M. Amin Khan
Rapid-Acting Antidepressants
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 2 Year: 2018 Page: 2556-2563
Author(s): Jeffrey M. Witkin,Daniel E. Knutson,Gabriel J. Rodriguez,Samuel Shi
Editorial (Thematic Selection: 'Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity')
Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 2-2
Author(s): Joseph R. Moskal
Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity
Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 3-10
Author(s): Jeffrey Burgdorf, Elizabeth M. Colechio, Patric Stanton, Jaak Panksepp
Synaptic Plasticity, Metaplasticity and Depression
Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 71-86
Author(s): Linnea R. Vose, Patric K. Stanton
Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants
Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 35-46
Author(s): Roger A. Kroes, Carol L. Nilsson
Animal Models of Schizophrenia and Associated Cognitive Dysfunction
Ebook: Animal Models for Neurological Disorders
Volume: 1 Year: 2021
Author(s): Kanwaljit Chopra,Navneet Dhaliwal,Tavish Gupta
Doi: 10.2174/9789815039689121010010
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
Journal: Current Neuropharmacology
Volume: 15 Issue: 7 Year: 2017 Page: 963-976
Author(s): Shigeyuki Chaki
Ketamine and Glutamatergic Compounds: Exploring Biomarkers and Mechanisms Related to Rapid Antidepressant Action
Ebook: Frontiers in Drug Discovery
Volume: 2 Year: 2017
Author(s): Gislaine Z. Réus,Helena M. Abelaira,Gerard Sanacora,João Quevedo
Doi: 10.2174/9781681084732117020010
Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 8 Year: 2017 Page: 858-869
Author(s): Gustavo H. Vazquez,Sebastian Camino,Leonardo Tondo,Ross J. Baldessarini